Division of Urology, Department of Surgery, University of Toronto, 399 Bathurst Street, MP-8-317, Toronto, Ontario M5T 2S8, Canada.
Division of Urology, Department of Surgery, University of Toronto, 399 Bathurst Street, MP-8-317, Toronto, Ontario M5T 2S8, Canada.
Urol Clin North Am. 2022 Feb;49(1):11-22. doi: 10.1016/j.ucl.2021.07.007. Epub 2021 Oct 25.
BPH is a common disease in aging men which impacts quality of life. With advancing age expectation coupled with the rising demand for BPH therapy, new technologies have been developed that target rapid recovery and symptom relief, low complication rates, and the ability to perform the procedure in an outpatient setting with local anesthesia. MIST technologies have fostered BPH medical care with ejaculation preservation. Techniques and outcomes for BPH technologies including Aquablation, Rezūm, UroLift, iTind, Optilume BPH, XFLO, Zenflow, and Butterfly are reviewed and evaluated. Given the novelty of these technologies, long-term data are required to assess safety and efficacy.
良性前列腺增生（BPH）是一种常见于老年男性的疾病，会影响生活质量。随着年龄的增长，人们对 BPH 治疗的需求不断增加，新技术应运而生，旨在实现快速康复和症状缓解、低并发症发生率，并能够在局麻下于门诊环境中进行操作。MIST 技术促进了具有保留射精功能的良性前列腺增生的医疗护理。本文对 Aquablation、Rezum、UroLift、iTind、Optilume BPH、XFLO、Zenflow 和 Butterfly 等 BPH 技术的技术和结果进行了回顾和评估。鉴于这些技术的新颖性，需要长期数据来评估其安全性和疗效。
